COVID-19èªå® çé¤/èªå® å¾ æ©ã«ããã£ã¦å½¹ç«ã¡ãããªãã®ãã¹ã¬ããã§ã¾ã¨ãã¦ããã ç¥ã£ã¦æã¯ãªãã¨æãã®ã§é©å½ã«åºãã¦ãããã¨ã
æ¥é£ã®è¦³å¯ã«ã¯å±éºãä¼´ãã¾ããéç°æ¥é£ã®æä¸ãå«ããã©ããªã«å¤ªé½ãæ¬ ããç¶æ ã§ã太é½ããã®ã¾ã¾ç´è¦ãã¦ã¯ã絶対ã«ããã¾ãããç´æ¥æ¥é£ã観å¯ããå ´åã«ã¯ãå¿ ããæ¥é£å°ç¨ã°ã©ã¹ãã使ç¨ãã¦ãã ããã ã¾ããæ¥é£å°ç¨ã°ã©ã¹ã®ä»£ç¨åã¨ãã¦ä»¥åãã使ããã¦ãã䏿·ãããããä»ããã¬ã©ã¹ãè²ã¬ã©ã¹ããµã³ã°ã©ã¹ãã´ã¼ã°ã«ãæå ããã«ã©ã¼ãã¬ãã£ã«ã ãã«ã¡ã©ç¨ã®NDï¼æ¸å ï¼ãã£ã«ã¿ã¼ãªã©ãéãã¦ã太é½ãç´è¦ãããã¨ã¯æ¥µãã¦å±éºã§ããç®ã«ã¯è¦ããªãæå®³ãªå ãç®ã®å¥¥ã«å±ãã¦ç¶²èãå·ã¤ãããã®çµæã失æãããæããããã¾ããéå»ã®æ¥é£ã§ããä¸è¨ã®ãããªå±éºãªæ¹æ³ã§è¦³å¯ããããã«ããæ¥é£ç¶²èçããªã©ãç¶²èãå·ã¤ãã¦ãã¾ã£ãçã®äºä¾ãå ±åããã¦ãã¾ããä»åã®æ¥é£ã§ããå±éºãªæ¹æ³ã§ã¯çµ¶å¯¾ã«è¦³å¯ããªããããç´°å¿ã®æ³¨æãæãã¾ãããã ã¾ããæ¥é£ã®èµ·ããæéããæã®éå¦ã»éå¤ã®æé帯ã«ããããããæ¥é£ã«æ°ãã¨ããã¦æãã¬
ç¹ã«æãã®ãªãéããè¨è¼ã®éé¡ã¯ãã¹ã¦ç¨è¾¼éé¡ã§ããæ¶è²»ç¨ã®è¨ç®ä¸ãå®éã®è«æ±é¡ã¨ç°ãªãå ´åãããã¾ãã ã»ãã¥ãªãã£å¯¾çã½ããããç³ãè¾¼ã¿æ¸ã¿ã®æ¹ã¸ åã»ãã¥ãªãã£å¯¾çã½ããããç³ãè¾¼ã¿å¾ããå©ç¨ã«ããã£ã¦ãã¤ã³ã¹ãã¼ã«ãè¡ãå¿ è¦ãããã¾ãã è¨å®å®äºãã¦ããªãæ¹ã¯ãä¸è¨ãããæç¶ãããé¡ããã¾ãã
ã¬ã½ãªã³ã®è²·ãç½®ãã¯å¤§å¤å±éºãªã®ã§æ¢ãã¾ããã ãåããã¦ã覧ãã ããã ï¼ã¬ã½ãªã³ï¼è²·ãã ãã»ããªå®¹å¨ä¿ç®¡ããã¦ãæ¶é²åºå¼ã³ãã 4æ1æ¥ã«ã¬ã½ãªã³ã®æ«å®ç¨çã®æéãåãããç¨éèªä½ã¯ã¬ã½ãªã³ã¹ã¿ã³ããè²·ã£ãæç¹ã§ä»ãã¦ããã®ã§ãæ¬æ¥ã¯4æ1æ¥ä»¥åã«è²·ã£ãã¬ã½ãªã³ãã¿ã³ã¯ã®ä¸ããç¡ããªããªãéãå¤ä¸ãã¯åºæ¥ãªãã®ã ãã©ä¸é¨ã®ã¬ã½ãªã³ã¹ã¿ã³ãã§ã¯å¤ä¸ãã«è¸ã¿ãã£ã¦ããã æ«å®ç¨çãã©ããªããã¯åãããªãããç¦ç°ç·çã®åããè¦ãã¨çµå±å ã«æ»ãã®ã§ã¯ã¨äºæ³ãããããã®ãããç¯æ²¹æè¦ã§ã¬ã½ãªã³ãè²·ãã ããå人ã§åèãããã¨ãã輩ãåºã¦ãããã¨ãæ¸å¿µããããããã¬ã½ãªã³ã®åèãã¡çµ¶å¯¾ãã§ãããã¬ã½ãªã³ã¯ç¯æ²¹ã¨ç°ãªãé屿§ã®å®¹å¨ã«ä¿åããªããã°ãªããªããç¯æ²¹ã¹ãã¼ããæ±ãæè¦ã§ã¬ã½ãªã³ãæ±ãã¨ãããç®ã«ããã åå æ²¸ç¹ å¼ç«ç¹ æå®æ°é ã¬ã½ãªã³ 30ã220â â40âä»¥ä¸ 200L ç¯æ²¹ 15
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}